Skip to main content

3M Earplug Attorneys Can Apply For Leadership Roles in MDL

3M Earplug Attorneys Can Apply For Leadership Roles in MDL

3M Earplug Attorneys Can Apply For Leadership Roles in MDL

Introduction

In a pretrial order issued on April 19, Judge Casey Rodgers, laid out the plaintiff leadership structure, asking product liability lawyers representing veterans in the 3M Earplug lawsuits to apply for various leadership roles in the recently formed multidistrict litigation (MDL).

The order calls for attorneys to apply for the position of lead counsel, liaison counsel, membership on an executive committee, steering committee, and a number of subcommittees. The attorneys appointed in these leadership roles will be responsible for certain actions during the trial proceedings that will be beneficial to all plaintiffs. These actions might include arguing motions before the court, taking depositions, reviewing discovery documents, among other actions. However, each veteran will still have their own attorney to represent the case-specific interests and assert claims that their hearing loss was caused due to faulty 3M Earplug. Any attorney who has his 3M Earplug case in the federal MDL will be allowed to apply for leadership roles, and the applications will be reviewed by May 3. Some attorneys will be called on May 20 and May 21, to make an oral presentation about their qualifications for the above-said positions.

The federal court system has more than 600 3M Earplug lawsuits with allegations that the device left veterans with tinnitus or hearing damage.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!